Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (2021) - Comments
pubmed: 33713817  doi: 10.1016/j.ijid.2021.03.015  issn: 1201-9712  issn: 1878-3511 

Anuja Pandit, Nirav Bhalani, B.L. Shashi Bhushan, Parshottam Koradia, Shweta Gargiya, Vinay Bhomia, Kevinkumar Kansagra